E-Mail
A brain pressure disorder that especially affects women, causing severe headaches and sometimes permanent sight loss, has risen six-fold in 15 years, and is linked to obesity and deprivation, a new study by Swansea University researchers has shown.
Rates of emergency hospital admissions in Wales for people with the disorder were also five times higher than for those without.
The condition is called idiopathic intracranial hypertension (IIH). It causes increased pressure in the fluid surrounding in the brain. This can lead to severely disabling headaches as well as vision loss, which can be permanent.
The research team, from Swansea University Medical School, used anonymised health records of Welsh patients held in the SAIL databank, a national healthcare database managed by the University. They analysed 35 million patient years of data from 2003 to 2017. They identified 1,765 people with IIH during that time, 85% of whom were women.
A new study has found a brain pressure disorder called idiopathic intracranial hypertension is on the rise, and the increase corresponds with rising obesity rates. The study is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that for women, socioeconomic factors like income, education and housing may play a role in their risk.
E-Mail
MINNEAPOLIS - A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of
Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more than half of the people with the secondary progressive form of MS experienced no worsening of their symptoms 10 years after a transplant.
Antioxidants Vitamin C and Vitamin E Linked to Lower Risk of Parkinson’s
MINNEAPOLIS - People who consume high levels of vitamin C and E in their diet may have a lower risk of Parkinson’s disease than people who get only small amounts of these nutrients, according to a new study published in the January 6, 2021, online issue of
®, the medical journal of the American Academy of Neurology.
“Improving diet is a known way to improve overall health, but the research on exactly how diet affects a person’s risk of Parkinson’s disease has been somewhat mixed,” said study author Essi Hantikainen, Ph.D., of University of Milano-Bicocca in Milan, Italy. “Our large study found that vitamin C and vitamin E were each linked to a 32% lower risk of Parkinson’s disease, and we found the association may be even stronger when intake of both vitamin C and E is high.”
Published: Jan 04, 2021
MARLBOROUGH, Mass., Jan. 4, 2021 /PRNewswire/ Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer s disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company s new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix s Chief Financial Officer (CFO).
Dr. Sadowsky is nationally renowned physician and researcher in AD and neurodegenerative diseases. He is a Clinical Professor of Neurology at Nova SE University and was the Founding Director of Research at the Palm Beach Neurology and Premiere Research Institute in West Palm Beach, Florida, a nationally recognized clinical research group focused on AD. Among his notable successes, Dr. Sadowsky has conducted over 300 Alzheimer s clinical trials, including the amyloid PET Amyvid trial and the IDEAS trial. He served on the scientific review board for Alzheimer s Drug Discovery Foundations (A